As immunotherapies are increasingly used for a range of cancers, new cases of rheumatic disease are likely to emerge. INTRODUCTION Immune checkpoint inhibitors are a group of medicines used to treat some cancers. They work with a person’s immune system to fight the cancer. Immune checkpoint inhibitors include drugs called nivolumab (also known by its […]
Month: January 2017
Ixekizumab: a new treatment option for people with PsA
Ixekizumab treatment resulted in improvements in disease activity and physical function in people with PsA. INTRODUCTION Psoriatic arthritis (often shortened to PsA) is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. The disease often causes swelling of the fingers and toes. It gets its name from the link between this […]
RA-BUILD shows clinical improvement with baricitinib
Baricitinib gives clinical improvement and inhibits joint damage in people with rheumatoid arthritis and an inadequate response or intolerance to csDMARDs INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It is more common in older people, and affects both men and women. Baricitinib is a new […]
